What Is High Risk for Breast Cancer? | Risk Series

Quick Answer: You are considered high risk for breast cancer if your lifetime risk is 20% or greater, or if you have specific risk factors - like a BRCA gene mutation or a history of chest radiation - that are known to dramatically elevate risk regardless of a score. High-risk women need a more intensive screening plan that typically starts earlier and includes breast MRI in addition to mammography.

The Risk Spectrum

Risk is a spectrum, not a simple category - and your screening plan should be personalized. The average woman's lifetime risk of breast cancer is approximately 13% (about 1 in 8).

<15%

Average Risk

Annual mammogram starting at 40. Routine surveillance.

15–20%

Elevated Risk

Above average but below the high-risk threshold. Managed individually. Supplemental ultrasound often discussed.

≥20%

High Risk

Qualifies for annual MRI plus mammogram, starting between ages 25–30.

Who Qualifies as High Risk?

Definite High-Risk Criteria (ACR / SBI)

Known carrier of a BRCA1 or BRCA2 gene mutation
First-degree relative of a BRCA1/BRCA2 carrier who has not yet been tested (treated as if they carry the mutation until tested)
Lifetime risk ≥20% as calculated by a validated risk model (Tyrer-Cuzick/IBIS, BOADICEA/CanRisk, or Claus model) based primarily on family history
History of chest radiation between ages 10 and 30 (e.g., for Hodgkin's lymphoma) - screening begins 8 years after radiation, no earlier than age 25
Known carrier of another high-risk gene mutation, including TP53 (Li-Fraumeni), PTEN (Cowden), STK11 (Peutz-Jeghers), CDH1, or PALB2 at high-risk thresholds
First-degree relative with one of the above syndromes who has not yet been tested themselves

Elevated Risk (Intermediate, 15–20%) - Needs Closer Monitoring

Personal history of breast cancer
History of atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), or lobular carcinoma in situ (LCIS)
Extremely dense breasts (BI-RADS Category D) combined with other risk factors
Significant family history that doesn't quite reach the 20% threshold on risk models

Risk Models Used to Calculate Your Score

Tool	What It Measures	Best Used For
Tyrer-Cuzick (IBIS)	10-year and lifetime risk	In-depth family history; most comprehensive; preferred by ACR
Gail Model (BCRAT)	5-year and lifetime risk	Quick estimate; primarily personal history; less sensitive for family history
Claus Model	Lifetime risk	Family history based; no personal risk factors
BOADICEA / CanRisk	Lifetime risk + mutation probability	Most complete; integrates genetic and non-genetic factors

A lifetime score of ≥20% on Tyrer-Cuzick or BOADICEA is the primary threshold for recommending supplemental MRI screening. The Gail model is less useful for identifying high risk based on family history - Tyrer-Cuzick is generally preferred for this purpose.

When Should You Get a Risk Assessment?

✓You are 25 or older and have never had a breast cancer risk discussion with your doctor

✓You have a first-degree relative with breast cancer diagnosed before age 50

✓You have multiple relatives on one side of your family with breast or ovarian cancer

✓You have a known BRCA mutation in your family and have not been tested

✓You received radiation to your chest as a child, teenager, or young adult

✓You have been told you had a high-risk benign biopsy (ADH, ALH, or LCIS)

✓You are Black or Ashkenazi Jewish - risk assessment by age 25 is specifically recommended by the ACR

✓Your standard screening mammogram showed extremely dense breasts (Category D) - combined with family history, this may push you into high-risk territory

How Your Risk Is Evaluated

Risk history intake

Your doctor or a genetic counselor collects a full personal and family history - including cancer diagnoses in first- and second-degree relatives, ages at diagnosis, types of cancer, whether cancers were bilateral, and your own personal history.

Risk model calculation

A validated lifetime risk tool is run (Tyrer-Cuzick is preferred). A lifetime score of ≥20% is the primary threshold for recommending supplemental MRI screening.

Genetic counseling and testing (when indicated)

If the risk model, family history pattern, or clinical features suggest possible hereditary risk, a referral to a certified genetic counselor is made for multi-gene panel testing.

Breast density assessment

Your mammogram result classifies your breast tissue as Category A through D. Density is factored into the overall risk picture, especially for decisions about supplemental screening.

High-Risk Screening Plan

If you are confirmed high risk (≥20% lifetime or qualifying factor), the ACR recommends a more intensive surveillance plan. MRI and mammogram are not done at the same time - they are offset by approximately 6 months, so your breast is being imaged twice a year in total.

Risk Category	Mammogram	Breast MRI
Known mutation (BRCA, etc.) or ≥20% lifetime risk	Annually from age 30	Annually from age 25–30
Chest radiation ages 10–30	Annually from 8 years post-radiation (min age 25)	Annually from 8 years post-radiation (min age 25)
TP53 mutation (Li-Fraumeni)	Consider avoiding; MRI preferred	Annually from age 20
Elevated risk (15–20%)	Annually from age 40	Discuss with doctor; not universally recommended

What Happens Next

Confirmed high risk

Personalized high-risk management plan including:

Annual mammogram and annual breast MRI (staggered ~6 months apart)
Clinical breast exam every 6–12 months starting at age 25
Referral to a high-risk breast program or breast specialist
Discussion of chemoprevention (tamoxifen, raloxifene, or aromatase inhibitors can reduce risk by up to 50%)
For BRCA carriers: discussion of risk-reducing surgery (preventive mastectomy ~90–95% risk reduction; preventive oophorectomy for ovarian cancer risk)

Elevated risk (15–20%)

Annual mammogram starting at 40; supplemental ultrasound often discussed; MRI considered on an individual basis depending on other factors such as dense breasts or prior biopsy findings.

Average risk (<15%)

Routine annual mammogram starting at age 40. Reassess if family history or clinical picture changes.

Frequently Asked Questions

My doctor said my lifetime risk is 18%. Does that mean I'm high risk?

Not quite by the standard definition. The threshold for "high risk" - and for supplemental MRI screening - is generally 20% or higher. At 18%, you are in the elevated (intermediate) risk zone, which is above average but below the high-risk threshold. Many doctors will discuss supplemental ultrasound for women in this range, and some will recommend MRI depending on other factors (like dense breasts or prior biopsy findings). The most important thing is that you are having this conversation with your doctor so your screening is personalized.

I was told I have LCIS. Does that make me high risk?

Lobular carcinoma in situ (LCIS) is a benign finding - it is not cancer - but it is a strong risk marker. Women with LCIS have approximately a 7–12 times higher lifetime risk of developing breast cancer compared to the general population, which typically places them well above the 20% lifetime risk threshold. Most guidelines classify women with LCIS as high risk and recommend annual mammography, with MRI also considered. Discuss with your doctor what surveillance plan is appropriate for you.

I have dense breasts. Am I automatically high risk?

Dense breasts alone do not automatically qualify you as high risk under the ≥20% lifetime risk definition. However, extremely dense breasts (BI-RADS Category D) are an independent risk factor, and when combined with family history, prior high-risk biopsy findings, or other factors, they can push your overall risk score into the high-risk category. Even if your calculated lifetime risk is below 20%, dense breasts may prompt your doctor to recommend supplemental ultrasound screening. Run your full history through a risk calculator with your doctor to get a complete picture.

What Is High Risk?